AccutarBio Company
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Last Funding Type:
Venture - Series Unknown
Funding Status:
Early Stage Venture
Headquarters:
Shanghai, Shanghai, China
Founded Date:
2015-01-01
Investor Type:
For Profit
Last Funding Date:
2021-01-05
Total Funding:
76613745.0
Technology:
Artificial Intelligence, Biopharma, Biotechnology, Machine Learning
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Investors Number:
3.0
Industry:
Early Drug Development